HC Wainwright Comments on Daré Bioscience, Inc.'s FY2027 Earnings (NASDAQ:DARE)

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – HC Wainwright issued their FY2027 earnings per share estimates for Daré Bioscience in a research note issued on Friday, March 31st. HC Wainwright analyst D. Tsao expects that the biotechnology company will post earnings of $0.80 per share for the year. HC Wainwright currently has a “Buy” […]

Related Keywords

Sabrina Martucci Johnson ,Lisa Walters Hoffert ,Founders Financial Securities ,Blackrock Inc ,Nasdaq ,Millennium Management ,Vanguard Group Inc ,Bioscience Inc ,Renaissance Technologies ,Get Rating ,Capital Management ,Bioscience Trading Down ,Financial Securities ,Bioscience Daily ,Daré Bioscience ,Nasdaq Dare ,Dare ,Medical ,Earnings Estimates ,Hc Wainwright ,